Department of Health Education, University of Bayreuth, Germany
Commentary
Comparative Effectiveness of Rituximab and Cladribine in Relapsing-Remitting Multiple Sclerosis: Insights from Target Trial Emulation
Author(s): Thaddeus Grey*
DOI:
10.4172/2329-6895.12.6.628
Neurological Disorders received 1343 citations as per Google Scholar report
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 